A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell
Di Han1, Xiao-Yan He2, Yun Huang3
1Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan, Hubei, 430072, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|August 17, 2023
Summary
This study developed a targeted delivery system to edit cancer genes, effectively inhibiting cancer cell fusion and metastasis. This approach offers a new strategy for personalized cancer therapy and precise fusion evaluation.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Cell fusion is crucial for cancer progression and metastasis.
- Current methods struggle to modulate and evaluate cell fusion for personalized therapy.
Purpose of the Study:
- To develop a multifunctional delivery vector for targeted gene editing and cell fusion detection in cancer.
- To inhibit cancer cell fusion and metastasis through epidermal growth factor receptor (EGFR) knockout.
Main Methods:
- Utilized a multifunctional delivery vector targeting circulating malignant cells (CMCs).
- Delivered a genome editing plasmid for EGFR knockout and a molecular beacon-based AND logic gate for fusion detection.
- Assessed cell fusion capability of edited versus unedited CMCs with human umbilical vein endothelial cells (HUVECs).
Main Results:
- The vector specifically targeted CMCs and delivered the gene editing payload.
- EGFR knockout significantly inhibited the cell fusion capability of CMCs.
- The AND logic gate reliably detected cell fusion events.
Conclusions:
- This strategy effectively modulates cancer cell fusion behavior and provides a tool for precise evaluation.
- Offers a novel therapeutic approach to prevent cancer progression and metastasis.
- Enables personalized therapy by evaluating cancer cell fusion accurately.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556


